Krensavage Asset Management, LLC Long-Term Concentrated

Location: New York, NY

CIK: 0001609251 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 14, 2016

Total Value: $277M (100.0% shares, 0.0% debt)

Holdings (17)

UTHR UNITED THERAPEUTICS CORP 11.8%
Value $32.56M Shares 275,764 Est. Cost $136.10 Unrealized -11.7%
OM2 ORTHOFIX INTERNATIONAL NV 9.9%
Value $27.37M Shares 639,851 Est. Cost $32.01 Unrealized
ENTA ENANTA PHARMACEUTICALS INC 9.6%
Value $26.6M Shares 999,741 Est. Cost $36.29 Unrealized -36.0%
IMPAX LABORATORIES INC 8.8%
Value $24.46M Shares 1,032,187 Est. Cost $30.42 Unrealized
AMGEN INC 7.6%
Value $21.02M Shares 126,038 Est. Cost $152.19 Unrealized
SUCAMPO PHARMACEUTICALS CL A 7.3%
Value $20.34M Shares 1,651,898 Est. Cost $12.18 Unrealized
HALYARD HEALTH INC 7.2%
Value $19.97M Shares 576,285 Est. Cost $40.74 Unrealized
INDIVIOR PLC 6.8%
Value $18.83M Shares 4,736,823 Est. Cost $3.34 Unrealized
TEVA TEVA PHARMACEUTICAL SP ADR 6.6%
Value $18.29M Shares 397,412 Est. Cost $58.35 Unrealized
MRK MERCK & CO INC 5.8%
Value $16.1M Shares 258,021 Est. Cost $39.26 Unrealized +11.4%
RTI SURGICAL INC 4.7%
Value $13.09M Shares 4,181,091 Est. Cost $4.41 Unrealized
CNMD CONMED CORP 4.7%
Value $13.05M Shares 325,785 Est. Cost $37.99 Unrealized +1.3%
INVACARE CORP 4.2%
Value $11.65M Shares 1,043,111 Est. Cost $14.06 Unrealized
AVIRAGEN THERAPEUTICS INC 1.9%
Value $5.21M Shares 2,713,517 Est. Cost $1.40 Unrealized
DERMA SCIENCES INC 1.5%
Value $4.128M Shares 884,000 Est. Cost $4.57 Unrealized
DIGIRAD CORP 0.9%
Value $2.459M Shares 482,121 Est. Cost $4.41 Unrealized
JUNIPER PHARMACEUTICALS INC 0.6%
Value $1.6M Shares 288,294 Est. Cost $9.19 Unrealized